Filing Details

Accession Number:
0001209191-19-021883
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-29 20:13:45
Reporting Period:
2019-03-27
Accepted Time:
2019-03-29 20:13:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406652 C Douglas Bryant 12544 High Bluff Drive, Suite 200
San Diego CA 92130
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-27 795 $12.63 302,237 No 4 M Direct
Common Stock Disposition 2019-03-27 795 $65.03 301,442 No 4 S Direct
Common Stock Acquisiton 2019-03-28 1,335 $12.63 302,777 No 4 M Direct
Common Stock Disposition 2019-03-28 1,335 $65.06 301,442 No 4 S Direct
Common Stock Acquisiton 2019-03-29 23,120 $12.63 324,562 No 4 M Direct
Common Stock Disposition 2019-03-29 23,120 $65.70 301,442 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option Disposition 2019-03-27 795 $0.00 795 $12.63
Common Stock Non-Qualified Stock Options Disposition 2019-03-28 1,335 $0.00 1,335 $12.63
Common Stock Non-Qualified Stock Options Disposition 2019-03-29 23,120 $0.00 23,120 $12.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,293 2021-03-02 No 4 M Direct
28,958 2021-03-02 No 4 M Direct
5,838 2021-03-02 No 4 M Direct
Footnotes
  1. The weighted average sale price for these transactions was $65.03 per share, with a range of $65.00 to $65.11. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  2. The weighted average sale price for these transactions was $65.062 per share, with a range of $65.03 to $65.08. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  3. The weighted average sale price for these transactions was $65.696 per share, with a range of $65.38 to $66.29. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  4. 42,959 shares vested on 03/02/2013; 21,479 shares vested on 03/02/2014; 21,480 shares vested on 03/02/2015.